---
title: "Major Investor Quietly Boosts Position in Sol-Gel Technologies"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291615493.md"
description: "Opaleye Management Inc. increased its stake in Sol-Gel Technologies (SLGL) by purchasing 1,712 shares valued at $123,218 on July 2, 2026, signaling institutional confidence. Concurrently, analysts initiated coverage with optimism regarding the SGT-610 program for Gorlin syndrome. TipRanks' AI Analyst rates SLGL as Neutral, citing strong financials and low debt but noting continued losses. The stock has seen a 70.84% YTD gain with a 'Buy' technical sentiment."
datetime: "2026-07-03T02:04:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291615493.md)
  - [en](https://longbridge.com/en/news/291615493.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291615493.md)
generator: "portal-rs"
---

# Major Investor Quietly Boosts Position in Sol-Gel Technologies

New insider activity at Sol-Gel Technologies ( (SLGL) ) has taken place on July 2, 2026.

Significant shareholder Opaleye Management Inc. has increased its stake in Sol-Gel Technologies by purchasing 1,712 shares of the company’s stock in a recent transaction. The deal is valued at $123,218, highlighting continued institutional confidence in Sol-Gel Technologies and adding notable weight to the company’s shareholder base.

In the last 24 hours, Sol-Gel Technologies drew positive analyst attention as coverage was initiated driven by optimism around its SGT-610 program for Gorlin syndrome. The drug is viewed as relatively de-risked because its hedgehog pathway mechanism is already validated by systemic inhibitors used off-label, and its potential to prevent new basal cell carcinoma lesions is seen as underappreciated at current share levels.

**Spark’s Take on SLGL Stock**

According to Spark, TipRanks’ AI Analyst, SLGL is a Neutral.

The score is driven primarily by improving financial trajectory (strong 2025 revenue rebound, positive operating/free cash flow, and very low debt) tempered by continued losses and equity erosion. Technicals are mixed/neutral, and valuation is pressured by a negative P/E and no dividend yield.

To see Spark’s full report on SLGL stock,  
 click here. 

**More about Sol-Gel Technologies**

**YTD Price Performance:** 70.84%

**Average Trading Volume:** 38,731

**Technical Sentiment Signal:** Buy

**Current Market Cap:** $235.3M

### Related Stocks

- [SLGL.US](https://longbridge.com/en/quote/SLGL.US.md)

## Related News & Research

- [Sol-Gel Therapeutics: Steady SGT-610 Execution and Capital-Efficient Growth Strategy Drive Price Target Increase to $195 and Support Buy Rating](https://longbridge.com/en/news/296514505.md)
- [Opaleye Management reports $68,006 purchase of Sol-Gel Technologies common shares](https://longbridge.com/en/news/295970228.md)
- [A mysterious free AI model is impressing developers. And nobody knows who made it.](https://longbridge.com/en/news/296687985.md)
- [Famous Hedge Fund Tiger Global Opened a New Position in This 1 AI Stock](https://longbridge.com/en/news/296381679.md)
- [Argentum AI Announces $10 Billion+ in Contracted Revenue and Targets 1GW of AI Infrastructure Capacity in 2026](https://longbridge.com/en/news/296261035.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**